Theravance, Inc. · South San Francisco, CA United States ·(NASDAQ (GM): THRX)
Company Description
Phone: 650-808-6000
Fax: 650-827-8690
View Theravance, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, next-generation treatments. Its development programs focus on respiratory disease, bacterial infections, and gastrointestinal disorders. In an exclusive alliance with GlaxoSmithKline (GSK), Theravance is developing a next-generation replacement for the druggernaut's asthma medication Advair. Its other lead product telavancin (developed in collaboration with Astellas ) is an injectable antibiotic that targets skin infections and hospital-acquired pneumonia. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Theravance, Inc. Financials
| Company Type | Public - NASDAQ (GM): THRX Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $23.1 |
| 2008 Employees | 191 |
Theravance, Inc. Executives
25 executives listed for Theravance, Inc.'s South San Francisco, CA location.
| Title | Name & Bio | Contact |
| Chairman | P. Roy Vagelos | Network |
| President, CEO, and Director | Rick Winningham | Network |
| SVP and CFO | Michael Aguiar | Network |
Competition
Competitive Landscape for Theravance, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Theravance, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!